-
Je něco špatně v tomto záznamu ?
Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
P. Knytl, V. Voráčková, A. Dorazilová, M. Rodriguez, A. Cvrčková, E. Kofroňová, M. Kuchař, Z. Kratochvílová, P. Šustová, S. Čerešňáková, P. Mohr,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
PubMed
31275177
DOI
10.3389/fpsyt.2019.00390
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Neuroactive steroids (NAS) affect neurotransmitter systems and cognition; thus, they play role in etiopathogenesis of psychiatric disorders. Aims: The primary aim was to examine cognition and effects of NAS on cognitive functioning in first-episode psychosis patients and in their healthy siblings. The secondary aims were to verify whether cognitive deficit is an endophenotype of psychosis and whether higher NAS levels represent a high-risk factor for psychosis. Methods: Studied participants were 1) patients with first episode of psychosis, 2) healthy siblings of the patients, and 3) matching healthy controls. Study procedures included administration of a battery of neuropsychological tests assessing six cognitive domains and examination of NAS plasma levels [cortisol (CORT), 11-deoxycorticosterone (DOC), testosterone (TEST), dehydroepiandrostendione (DHEA), dihydrotestosterone (DHT), and progesterone (PROG)]. Results: A total of 67 subjects were analyzed (16 patients, 22 siblings, and 29 controls). Significant group differences were found in most of the cognitive domains; the patients had the lowest scores. The Kruskal-Wallis test revealed significant group differences in CORT levels (p < 0.01), TEST (p < 0.01), and DHT (p < 0.001); no difference was found in PROG, DHEA, and DOC. All cognitive domains, except for attention, were affected by the NAS levels. CORT levels of patients correlated with speed of processing (r = 0.55) and working memory (r = 0.52), while PROG levels correlated with abstraction (r = -0.63). In siblings, there was a negative correlation between TEST levels and verbal memory (r = -0.51) and PROG with attention (r = -0.47). Conclusions: Our results verified that individual domains of cognitive deficit (abstraction and verbal memory) can be considered as an endophenotype of psychosis. Higher levels of cortisol and testosterone in siblings are consistent with high-risk states for psychosis. Multiple interactions between NAS and cognitive functioning, particularly memory functions, were observed. Study limitations (small sample size and administration of antipsychotic medication) did not allow us to establish unequivocally NAS as an endophenotype.
National Institute of Mental Health Klecany Czechia
National Institute of Mental Health Klecany Czechia Faculty of Arts Masaryk University Brno Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035981
- 003
- CZ-PrNML
- 005
- 20200317162714.0
- 007
- ta
- 008
- 191007s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fpsyt.2019.00390 $2 doi
- 035 __
- $a (PubMed)31275177
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Knytl, Pavel $u National Institute of Mental Health, Klecany, Czechia. Third Faculty of Medicine, Charles University, Prague, Czechia.
- 245 10
- $a Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings / $c P. Knytl, V. Voráčková, A. Dorazilová, M. Rodriguez, A. Cvrčková, E. Kofroňová, M. Kuchař, Z. Kratochvílová, P. Šustová, S. Čerešňáková, P. Mohr,
- 520 9_
- $a Background: Neuroactive steroids (NAS) affect neurotransmitter systems and cognition; thus, they play role in etiopathogenesis of psychiatric disorders. Aims: The primary aim was to examine cognition and effects of NAS on cognitive functioning in first-episode psychosis patients and in their healthy siblings. The secondary aims were to verify whether cognitive deficit is an endophenotype of psychosis and whether higher NAS levels represent a high-risk factor for psychosis. Methods: Studied participants were 1) patients with first episode of psychosis, 2) healthy siblings of the patients, and 3) matching healthy controls. Study procedures included administration of a battery of neuropsychological tests assessing six cognitive domains and examination of NAS plasma levels [cortisol (CORT), 11-deoxycorticosterone (DOC), testosterone (TEST), dehydroepiandrostendione (DHEA), dihydrotestosterone (DHT), and progesterone (PROG)]. Results: A total of 67 subjects were analyzed (16 patients, 22 siblings, and 29 controls). Significant group differences were found in most of the cognitive domains; the patients had the lowest scores. The Kruskal-Wallis test revealed significant group differences in CORT levels (p < 0.01), TEST (p < 0.01), and DHT (p < 0.001); no difference was found in PROG, DHEA, and DOC. All cognitive domains, except for attention, were affected by the NAS levels. CORT levels of patients correlated with speed of processing (r = 0.55) and working memory (r = 0.52), while PROG levels correlated with abstraction (r = -0.63). In siblings, there was a negative correlation between TEST levels and verbal memory (r = -0.51) and PROG with attention (r = -0.47). Conclusions: Our results verified that individual domains of cognitive deficit (abstraction and verbal memory) can be considered as an endophenotype of psychosis. Higher levels of cortisol and testosterone in siblings are consistent with high-risk states for psychosis. Multiple interactions between NAS and cognitive functioning, particularly memory functions, were observed. Study limitations (small sample size and administration of antipsychotic medication) did not allow us to establish unequivocally NAS as an endophenotype.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Voráčková, Veronika $u National Institute of Mental Health, Klecany, Czechia. Third Faculty of Medicine, Charles University, Prague, Czechia.
- 700 1_
- $a Dorazilová, Aneta $u National Institute of Mental Health, Klecany, Czechia. Faculty of Arts, Masaryk University, Brno, Czechia.
- 700 1_
- $a Rodriguez Manchola, Rachel Virginia $u National Institute of Mental Health, Klecany, Czechia. Faculty of Arts, Charles University, Prague, Czechia. $7 xx0230299
- 700 1_
- $a Cvrčková, Aneta $u National Institute of Mental Health, Klecany, Czechia. Faculty of Social Studies, Masaryk University, Brno, Czechia.
- 700 1_
- $a Kofroňová, Edita $u University of Chemistry and Technology, Prague, Czechia.
- 700 1_
- $a Kuchař, Martin $u National Institute of Mental Health, Klecany, Czechia. University of Chemistry and Technology, Prague, Czechia.
- 700 1_
- $a Kratochvílová, Zuzana $u National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Šustová, Petra $u National Institute of Mental Health, Klecany, Czechia.
- 700 1_
- $a Čerešňáková, Silvie $u National Institute of Mental Health, Klecany, Czechia. First Faculty of Medicine, Charles University, Prague, Czechia.
- 700 1_
- $a Mohr, Pavel $u National Institute of Mental Health, Klecany, Czechia. Third Faculty of Medicine, Charles University, Prague, Czechia.
- 773 0_
- $w MED00174602 $t Frontiers in psychiatry $x 1664-0640 $g Roč. 10, č. - (2019), s. 390
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31275177 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20200317163138 $b ABA008
- 999 __
- $a ind $b bmc $g 1452641 $s 1074531
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c - $d 390 $e 20190618 $i 1664-0640 $m Frontiers in psychiatry $n Front Psychiatry $x MED00174602
- LZP __
- $a Pubmed-20191007